NeoGenomics, Inc. (NASDAQ: NEO) Q4 2025 earnings call transcript

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript February 17, 2026 NeoGenomics, Inc. misses on earnings ...

NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 17, 2026 8:30 AM ESTCompany ParticipantsKendra Sweeney - Vice President of Investor Relations ...
The Hill

Possible Las Vegas ‘biological lab’ may be linked to illegal medical lab in California

LAS VEGAS (KLAS) – A possible biological laboratory found at a home in Las Vegas on Saturday may be connected to a similar incident in California, where officials found infectious agents such as HIV ...
Yahoo Finance

NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

FORT MYERS, Fla., January 27, 2026--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will ...
The Globe and Mail

NeoGenomics Announces Board Changes to Support Future Growth

NeoGenomics ( (NEO)) has shared an announcement. On December 23, 2025, NeoGenomics’ board accepted the resignation of long-serving director Dr. Alison L. Hannah, effective December 31, 2025, and ...
Business Wire

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics ...
Times Argus

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran ...